Norges Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,311,485
| Closed | -$1.01B | – | 1084 |
|
|
2025
Q4 | $1.01B | Buy |
+1,311,485
| New | +$891M | 0.11% | 161 |
|
|
2025
Q3 | – | Sell |
-1,196,479
| Closed | -$628M | – | 1208 |
|
|
2025
Q2 | $628M | Buy |
1,196,479
+67,955
| +6% | +$37.9M | 0.08% | 235 |
|
|
2025
Q1 | $716M | Buy |
1,128,524
+2,591
| +0.2% | +$1.78M | 0.1% | 185 |
|
|
2024
Q4 | $802M | Buy |
1,125,933
+3,827
| +0.3% | +$3.21M | 0.11% | 177 |
|
|
2024
Q3 | $1.18B | Sell |
1,122,106
-4,842
| -0.4% | -$5.39M | 0.16% | 118 |
|
|
2024
Q2 | $1.18B | Buy |
1,126,948
+22,674
| +2% | +$22M | 0.18% | 104 |
|
|
2024
Q1 | $1.06B | Buy |
1,104,274
+42,471
| +4% | +$40.4M | 0.17% | 120 |
|
|
2023
Q4 | $933M | Buy |
1,061,803
+3,051
| +0.3% | +$2.51M | 0.16% | 128 |
|
|
2023
Q3 | $871M | Buy |
1,058,752
+12,397
| +1% | +$9.74M | 0.18% | 118 |
|
|
2023
Q2 | $752M | Buy |
1,046,355
+45,242
| +5% | +$34.9M | 0.15% | 133 |
|
|
2023
Q1 | $823M | Buy |
1,001,113
+34,646
| +4% | +$26.1M | 0.18% | 111 |
|
|
2022
Q4 | $697M | Buy |
966,467
+59,854
| +7% | +$44.2M | 0.17% | 124 |
|
|
2022
Q3 | $625M | Buy |
906,613
+24,303
| +3% | +$15.3M | 0.17% | 114 |
|
|
2022
Q2 | $522M | Sell |
882,310
-105,326
| -11% | -$68.5M | 0.13% | 153 |
|
|
2022
Q1 | $690M | Buy |
987,636
+22,945
| +2% | +$14.5M | 0.15% | 129 |
|
|
2021
Q4 | $609M | Sell |
964,691
-15,695
| -2% | -$9.65M | 0.13% | 151 |
|
|
2021
Q3 | $593M | Sell |
980,386
-56,321
| -5% | -$35M | 0.13% | 150 |
|
|
2021
Q2 | $579M | Buy |
1,036,707
+56,299
| +6% | +$28.5M | 0.13% | 161 |
|
|
2021
Q1 | $464M | Sell |
980,408
-68,709
| -7% | -$33.5M | 0.11% | 184 |
|
|
2020
Q4 | $507M | Sell |
1,049,117
-122,982
| -10% | -$66.4M | 0.12% | 166 |
|
|
2020
Q3 | $656M | Sell |
1,172,099
-81,428
| -6% | -$49.4M | 0.17% | 107 |
|
|
2020
Q2 | $782M | Buy |
1,253,527
+433,272
| +53% | +$246M | 0.23% | 75 |
|
|
2020
Q1 | $401M | Buy |
820,255
+3,375
| +0.4% | +$1.39M | 0.14% | 140 |
|
|
2019
Q4 | $307M | Hold |
816,880
| – | – | 0.09% | 220 |
|
|
2019
Q3 | $227M | Hold |
816,880
| – | – | 0.07% | 268 |
|
|
2019
Q2 | $256M | Buy |
816,880
+16,098
| +2% | +$5.36M | 0.08% | 246 |
|
|
2019
Q1 | $329M | Buy |
800,782
+17,765
| +2% | +$7.32M | 0.11% | 182 |
|
|
2018
Q4 | $292M | Hold |
783,017
| – | – | 0.11% | 185 |
|
|
2018
Q3 | $316M | Sell |
783,017
-47,021
| -6% | -$17.9M | 0.1% | 184 |
|
|
2018
Q2 | $286M | Buy |
830,038
+5,079
| +0.6% | +$1.59M | 0.1% | 209 |
|
|
2018
Q1 | $284M | Buy |
824,959
+29,491
| +4% | +$10.3M | 0.1% | 195 |
|
|
2017
Q4 | $299M | Buy |
795,468
+38,756
| +5% | +$15.7M | 0.11% | 192 |
|
|
2017
Q3 | $338M | Sell |
756,712
-19,657
| -3% | -$9.35M | 0.13% | 163 |
|
|
2017
Q2 | $381M | Sell |
776,369
-8,024
| -1% | -$3.51M | 0.15% | 131 |
|
|
2017
Q1 | $304M | Sell |
784,393
-9,850
| -1% | -$3.65M | 0.12% | 164 |
|
|
2016
Q4 | $292M | Sell |
794,243
-1,291
| -0.2% | -$491K | 0.13% | 164 |
|
|
2016
Q3 | $305M | Buy |
795,534
+83,194
| +12% | +$33.4M | 0.14% | 132 |
|
|
2016
Q2 | $249M | Buy |
712,340
+13,745
| +2% | +$5.29M | 0.12% | 171 |
|
|
2016
Q1 | $252M | Sell |
698,595
-15,499
| -2% | -$6.39M | 0.12% | 160 |
|
|
2015
Q4 | $388M | Sell |
714,094
-37,296
| -5% | -$20.2M | 0.19% | 102 |
|
|
2015
Q3 | $350M | Buy |
751,390
+14,939
| +2% | +$8.02M | 0.18% | 107 |
|
|
2015
Q2 | $376M | Buy |
736,451
+18,748
| +3% | +$9.15M | 0.19% | 107 |
|
|
2015
Q1 | $324M | Buy |
717,703
+28,635
| +4% | +$12.1M | 0.16% | 126 |
|
|
2014
Q4 | $283M | Buy |
689,068
+16,645
| +2% | +$6.55M | 0.14% | 135 |
|
|
2014
Q3 | $242M | Sell |
672,423
-622,423
| -48% | -$209M | 0.13% | 149 |
|
|
2014
Q2 | $366M | Buy |
1,294,846
+652,285
| +102% | +$193M | 0.1% | 203 |
|
|
2014
Q1 | $193M | Buy |
642,561
+9,148
| +1% | +$2.82M | 0.11% | 184 |
|
|
2013
Q4 | $174M | Sell |
633,413
-55,619
| -8% | -$16M | 0.1% | 200 |
|
|
2013
Q3 | $216M | Buy |
689,032
+42,596
| +7% | +$11.2M | 0.13% | 158 |
|
|
2013
Q2 | $145M | Buy |
+646,436
| New | +$151M | 0.09% | 224 |
|
Other funds holding REGN
VCM
N
Norges Bank's REGN Position: Q1 2026 in Review
Norges Bank sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 1,311,485 shares — an estimated $1.01B sold.
Norges Bank first reported a position in REGN in Q2 2013 and held it in 50 quarters. The position peaked at $1.18B in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Norges Bank reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Norges Bank sold 1,311,485 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.01B.
- Norges Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- Norges Bank's Regeneron Pharmaceuticals position peaked at $1.18B in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Norges Bank's 13F filing for Q1 2026.